Present and future possibilities for early diagnosis of hepatocellular carcinoma
Open Access
- 1 January 2010
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 16 (4), 418-424
- https://doi.org/10.3748/wjg.v16.i4.418
Abstract
Hepatocellular carcinoma (HCC) represents the fifth most common cancer in the world, and the third most frequent oncological cause of death. The incidence of HCC is on the increase. HCC typically develops in patients with chronic liver diseases, and cirrhosis, usually with viral etiology, is the strongest predisposing factor. Nowadays HCC diagnosis is a multistage process including clinical, laboratory, imaging and pathological examinations. The prognosis of HCC is mostly poor, because of detection at an advanced, non-resectable stage. Potentially curative treatment (surgery) is limited and really possible only for cases with small HCC malignancies. For this reason, more effective surveillance strategies should be used to screen for early occurrence of HCC targeted to the population at risk. So far, the generally accepted serological marker is α-fetoprotein (AFP). Its diagnostic accuracy is unsatisfactory and questionable because of low sensitivity, therefore there is a strong demand by clinicians for new HCC-specific biomarkers. In this review, we will focus on other biomarkers that seem to improve HCC diagnosis, such as AFP-L3, des-γ-carboxyprothrombin, α-l-fucosidase, γ-glutamyl transferase, glypican-3, squamous cell carcinoma antigen, a new generation of immunoglobulin M-immunocomplexes, and very promising gene-expression profiling.Keywords
This publication has 71 references indexed in Scilit:
- Early and Late Recurrence After Liver Resection for Hepatocellular CarcinomaAnnals of Surgery, 2006
- Detection of serum and intrahepatic KL-6 in anti-HCV positive patients with hepatocellular carcinomaHepatology Research, 2004
- Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinomaBritish Journal of Cancer, 2004
- Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver diseaseJournal of Hepatology, 2002
- Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trialsJournal of Hepatology, 1999
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombinLiver Transplantation and Surgery, 1995
- Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditionsGastroenterology, 1990
- The heterogeneity of the serum activity of γ-glutamyl transpeptidase in hepatobiliary diseases as studied by agarose gel electrophoresisClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Über die bedeutung der isoenzyme der γ-glutamyl-trans-peptidase in der klinischen diagnostikClinica Chimica Acta; International Journal of Clinical Chemistry, 1965